United States · FDA National Drug Code directory

Guaifenesin and Pseudoephedrine Hydrochloride

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 41415-994_a36d0524-b1d7-4daf-a62e-54f63168b0cd
Product NDC: 41415-994
Form: TABLET, EXTENDED RELEASE
Composition / generic term: Guaifenesin and Pseudoephedrine Hydrochloride
Labeler: PUBLIX SUPER MARKETS, INC
Marketing category: ANDA
Marketing start / end (source format): 20220407
Source listing expiry: 20261231

Source-listed ingredients

GUAIFENESIN — 600 mg/1
PSEUDOEPHEDRINE HYDROCHLORIDE — 60 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

1 BLISTER PACK in 1 CARTON (41415-994-18) / 18 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · 41415-994-18
2 BLISTER PACK in 1 CARTON (41415-994-36) / 18 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · 41415-994-36

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →